All Episodes

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1

Systemic Treatment of Thyroid Cancer Guideline

Patient-Clinician Communication Guideline Update

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update

White Blood Cell Growth Factors Guideline Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1

Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1

Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline

Management of Cancer During Pregnancy Guideline

Management of Antineoplastic Extravasation: ONS-ASCO Guideline

Postmastectomy Radiation Therapy: ASTRO-ASCO-SSO Guideline

Geriatric Assessment Global Guideline

Oncology Medical Homes: ASCO-COA Standards Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2025.1 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2025.1 Part 1

Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards Update

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Guideline

Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Guideline Update

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Rapid Update

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Guideline Update

Fertility Preservation in People with Cancer Guideline Update

Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2024.3 Part 1

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.3 Part 2

TORS in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma Guideline

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update

Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline

Treatment of Pleural Mesothelioma Update

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline

Systemic Therapy for SCLC Rapid Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2

Management of Locally Advanced Rectal Cancer Guideline

Management of Stage III NSCLC Rapid Update

Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update

Management of Fatigue in Adult Survivors of Cancer: ASCO-SIO Guideline Update

Palliative Care for Patients with Cancer Guideline Update

Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy: ISOO-MASCC-ASCO Guideline

Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations

Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update

Vaccination of Adults with Cancer Guideline

Cannabis and Cannabinoids in Adults with Cancer Guideline

Endocrine and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer – Capivasertib-Fulvestrant: Rapid Guideline Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.3 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1

Systemic Treatment of Patients with Metastatic Breast Cancer Resource-Stratified Guideline

Germline Testing in Patients with Breast Cancer: ASCO-SSO Guideline

Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline

Management of Metastatic Renal Clear Cell Cancer Rapid Recommendation Update

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs Guideline

Systemic Therapy for Melanoma Guideline Update

Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: SIO-ASCO Guideline

Management of Stage III NSCLC Rapid Recommendation Update

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Guideline Update

Cancer Cachexia Rapid Recommendation Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.2

HER2 Testing in Breast Cancer: ASCO-CAP Guideline Update

Testing for ESR1 Mutations to Guide Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Rapid Recommendation Update

VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update

Management of Anxiety and Depression in Adult Survivors of Cancer Guideline Update

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.1 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.1 Part 1

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

Penile Cancer: EAU-ASCO Guideline

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer Rapid Recommendation Update

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of CAP Guideline

Targeted Therapy and Immunotherapy for Gastroesophageal Cancer Guideline

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2022.2 Part 2

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2022.2 Part 1

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers Guideline

Use of Opioids for Adults with Pain from Cancer or Cancer Treatment Guideline

Treatment of Metastatic Colorectal Cancer Guideline

PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update

Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline

Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)

Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)

Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline Update

Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline

Systemic Therapy for Melanoma Rapid Recommendation Update

Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update

Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update

Exercise, Diet, and Weight Management During Cancer Treatment Guideline

Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update

Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update

Management and Care of Patients with Invasive Cervical Cancer: Resource-Stratified Guideline Rapid Recommendation Update

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer Provisional Clinical Opinion

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected NSCLC Guideline Rapid Recommendation Update

Management of Stage III NSCLC Guideline

Adjuvant Therapy for Stage II Colon Cancer Guideline Update

Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline

Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)

Ocular Toxicities: Management of irAEs Guideline (Part 12)

Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)

Hematologic Toxicities: Management of irAEs Guideline (Part 10)

Nervous System Toxicities: Management of irAEs Guideline (Part 9)

Renal Toxicities: Management of irAEs Guideline (Part 8)

Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)

Endocrine Toxicities: Management of irAEs Guideline (Part 6)

Lung Toxicities: Management of irAEs Guideline (Part 5)

Gastrointestinal Toxicities: Management of irAEs Guideline (Part 4)

Cutaneous Toxicities: Management of irAEs Guideline (Part 3)

ICPi Overview: Management of irAEs Guideline (Part 1)

CAR-T Cell Therapy: Management of irAEs Guideline (Part 2)

Immunotherapy in Patients with Locally Advanced Esophageal Carcinoma: ASCO Guideline Rapid Recommendation Update

Adjuvant PARP Inhibitors in Patients with High-risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update

Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guideline Update

Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update

Telehealth in Oncology: Standards and Practice Recommendations

Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline

Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline

Oncology Medical Home: ASCO and COA Standards

Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer Resource Stratified Guideline

Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer Guideline Update

Management of Salivary Gland Malignancy Guideline

Management of Dyspnea in Advanced Cancer Guideline

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline

Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement

Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

PREVIEW: ASCO in Action CEO & CMO Interview

Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma: CSCO-ASCO Guideline

Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Update

Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline

PARP Inhibitors in the Management of Ovarian Cancer Guideline

Metastatic Pancreatic Cancer Guideline Update

Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy Provisional Clinical Opinion Update

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers Guideline Update

Antiemetics Guideline Update

Treatment of Locally Advanced Esophageal Carcinoma Guideline

Management of Cancer Cachexia Guideline

Lung Cancer Surveillance After Definitive Curative-Intent Therapy Guideline

Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Guideline

Management of Hereditary Breast Cancer Guideline

Systemic Therapy for Melanoma Guideline

Treatment of Patients with Late-Stage Colorectal Cancer Resource-Stratified Guideline

Management of Male Breast Cancer Guideline

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations Guideline

Bone Health and Bone-Targeted Therapies for Prostate Cancer Guideline Endorsement

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer Guideline

Optimum Imaging Strategies for Advanced Prostate Cancer Guideline

Estrogen and Progesterone Receptor Testing in Breast Cancer Guideline Update

Molecular Biomarkers in Localized Prostate Cancer Guideline

Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards

Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease Guideline

Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline

Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer Guideline Update

Medication-Related Osteonecrosis of the Jaw Guideline

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update

Potentially Curable Pancreatic Adenocarcinoma Guideline Update

Use of Biomarkers to Guide Decisions on Adjuvant Therapy for Early-Stage Invasive Breast Cancer Guideline Update

Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer PCO

Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer Guideline

Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents Guideline

Treatment of Multiple Myeloma Guideline

Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors Endorsement

Adjuvant Therapy for Resected Biliary Tract Cancer Guideline

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline

Early Detection for Colorectal Cancer Resource-Stratified Guideline

Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline

Safe Handling of Hazardous Drugs: ASCO Standards

Initial Diagnostic Workup of Acute Leukemia Guideline

Evaluating Susceptibility to Pancreatic Cancer PCO

Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer Guideline

Hypofractionated Radiation Therapy for Localized Prostate Cancer Guideline

Human Papillomavirus Testing in Head and Neck Carcinomas Endorsement Guideline

Clinically Localized Prostate Cancer Endorsement Guideline

Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline

Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline

Systemic Therapy for Patients with Advanced HER2 Positive Breast Cancer Guideline

Integrative Therapies During and After Breast Cancer Treatment Guideline

Treatment of Malignant Pleural Mesothelioma Guideline

HER2 Testing in Breast Cancer Guideline

Metastatic Pancreatic Cancer Guideline

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline

Practical Assessment and Management of Vulnerabilities in Older Patients Guideline

ASCO Clinical Practice Guidelines Committee Leadership

Palliative Care in the Global Setting Guideline

Antiemetics Guideline

Patient-Clinician Communication Consensus Guideline

Integration of Palliative Care into Oncology Guideline

Fertility Preservation in Patients with Cancer Guideline

Optimizing Anticancer Therapy in Prostate Cancer Guideline

Outpatient Management of Fever and Neutropenia Guideline

Management of Immune-Related Adverse Events Guideline